Home Pharmaceuticals Australia IVD Raw Materials Market Size And Share Report By 2033

Australia IVD Raw Materials Market Size & Outlook, 2025-2033

Australia IVD Raw Materials Market Size

According to Straits Research analysis, the Australia IVD Raw Materials Market was valued at USD 219.34 Million in 2024 and is projected to reach USD 784.73 Million by 2033, expanding at a CAGR of 15.4% during the forecast period. The market's growth is predominantly driven by demand from agriculture, chemicals, and energy sectors for industrial usage. The surge in need for tailored patient care in the healthcare industry has significantly boosted the demand for IVD raw materials, contributing to the industry's growth. Recent trends have seen a shift towards greener, low-carbon production methods and technological advancements, offering new market opportunities. Additionally, Australia is capitalising on the potential for increased exports in the Asia-Pacific region. The country's strategic investments and focus on sustainability are positioning it as a significant player in the global IVD Raw Materials market.

Australia IVD Raw Materials Market Highlights

  • In 2024, Antibody accounted for the highest share of the Product Type market size.
  • During the forecast period, Proteins is set to register the highest growth, making it the most lucrative Product Type segment.
  • In 2024, Australia accounted for 1.35% of the global ivd raw materials market size.
  • By 2033, United States is expected to lead the global ivd raw materials market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional ivd raw materials market size by 2033.
  • India is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 454.85 Million by 2033.

Australia IVD Raw Materials Market Revenue Share 2024

  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2020-2033
Historical Period 2020-2023
Forecast Period 2025-2033
Market Size In 2024 USD 219.34 Million
Market Size In 2033 USD 784.73 Million
Largest segment Antibody
Fastest segment Proteins
Units Revenue in USD Million
CAGR 15.4% (2025-2033)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Segmentation Covered

Segments Sub Segments
Product Type
  1. Antibody
  2. Antigens
  3. Proteins
  4. Enzymes
  5. Biological Buffers
  6. Substrates
  7. Others
Technology
  1. Molecular Diagnostics
  2. Clinical Chemistry
  3. Immunochemistry
  4. Other
End User
  1. Diagnostic Laboratories
  2. Pharmaceutical & Biotechnological Companies
  3. Others
WhatsApp
Chat with us on WhatsApp